Show: 1 - 14 of 14 results

Asia Pacific Trial Sector Poised for Continued Growth

[August 26, 2010] - The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients ...

CMOs in India, China to Grow at 20 Percent

[February 12, 2010] - The economic pressures of the past 18 months have clearly accelerated the cost reduction efforts ...

Is 'One-Stop Shopping' in Contract Biopharma a Good Thing?

[February 08, 2010] - We've all heard the pitch from the contract development vendor: "Buy from us because we can provide ALL the services you’ll need!" ...

Bangladesh a "Huge Opportunity" for CMO Growth

[September 09, 2009] - According to the CEO of Amreteck Pharma who believes that CMOs will be attracted by the low costs, which undercut China ...

Innovation Marks Steady Growth of Asian Biotech

[September 01, 2009] - The conversation about outsourcing to Asia has changed from cost reduction to opportunity ...

Preclinical CRO Markets: China vs India

[July 09, 2009] - In many aspects China and India are very similar. Both are located in Asia and the most populated countries in the world ...

Opportunities in Uncertain Times

[June 29, 2009] - The Pharmaceutical industry is undergoing significant change, from drug development philosophy and tightening ...

Asian CMOs in Demand

[June 10, 2009] - The global pharmaceutical industry has been facing many challenges in the form of increasing competition from generics ...

Pharmaceutical Outsourcing: Opportunity for India!

[May 18, 2009] - The global pharmaceutical markets were estimated at US$712bn in the year 2008 growing at 6.4 percent over 2006 ...

CMO: A Seat at the Table

[April 23, 2009] - One of the drivers for this trend is that as the marketplace becomes more fragmented and there are more ...

Is China Too Expensive?

[November 05, 2008] - Labor shortages, wage inflation, rising taxes and Renminbi appreciation drive some to conclude that China's heyday is over ...

All Korean CROs are Clinical CROs

[September 10, 2008] - In an interview, Ms Mi-Yang Kim, Executive Director, C&R Research Korea shared her views about the opportunity ...

Sundia's CEO On Driving Innovation In China's Pharma Sector

[September 09, 2008] - China's ballooning middle class, born of market reforms, the extension of health insurance to a widening sector ...

There's More Than Meets the Eye to China's CRO Sector

[July 09, 2008] - Part of China's appeal to foreign investors has always been its cost advantage, but according to pharmaceutical industry experts ...

«  First Prev Next Last    Total 14 Records, 1/1 Page  »